Women carry a higher burden of Alzheimer's disease (AD) compared to men, which is not
accounted entirely by differences in lifespan. To identify the mechanisms underlying this …

The study of sex differences in Alzheimer's disease is increasingly recognized as a key
priority in research and clinical development. People with Down syndrome represent the …

Background “Brain-predicted age” estimates biological age from complex, nonlinear
features in neuroimaging scans. The brain age gap (BAG) between predicted and …

INTRODUCTION Plasma tau phosphorylated at threonine 217 (P‐tau217) and
neurofilament light (NfL) have emerged as markers of Alzheimer's disease (AD) pathology …

Introduction Females may have greater susceptibility to Alzheimer's disease (AD)‐
pathology. We examined the effect of sex on pathology, neurodegeneration, and memory in …

We aimed to study atrophy and glucose metabolism of the cholinergic basal forebrain in non-
demented mutation carriers for autosomal dominant Alzheimer's disease (ADAD). We …

Impairments in activities of daily living (ADL) are common clinical symptoms of human
Alzheimer's disease (AD). Describing the ADL in AD animal models might provide more …

Alzheimer's disease (AD) is a progressive cognitive disorder that occurs worldwide, and the
lack of disease-modifying targets and pathways is a pressing issue. This study aimed to …

INTRODUCTION Studies suggest distinct differences in the development, presentation,
progression, and response to treatment of Alzheimer's disease (AD) between females and …

Objective: Subjective Cognitive Decline (SCD) may be an early indicator of risk for
Alzheimer's disease (AD). Findings regarding sex differences in SCD are inconsistent …